Kubesch A, Lande R, Leutgob A, Farrag K, et al. Sequencing Therapy for Optimal Response in Mirikizumab (STORM)-study: A tertiary referral center study on patients with therapy-refractory ulcerative colitis. PLoS One 2025;20:e0334897.
PMID: 41134755